Ikena Oncology Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-68.17	-68.77	-34.12	-44.26	-16.82
Depreciation & Amortization	2.73	2.03	1.72	1.26	0.12
Share-Based Compensation	7.63	7.53	5.18	1.8	1.17
Other Operating Activities	-21.94	-14.9	-33.03	3.37	63.45
Operating Cash Flow	-79.74	-74.11	-60.25	-37.83	47.93
Capital Expenditures	-0.41	-1.43	-1.76	-0.77	-0.32
Acquisitions	0	0	0	3.69	0
Change in Investments	64.56	-97.85	0	0	0
Investing Cash Flow	64.14	-99.28	-1.76	2.92	-0.32
Share Issuance / Repurchase	36.89	1.1	131.88	0.01	0.03
Other Financing Activities	39.09	-	-0.15	116.17	16.29
Financing Cash Flow	75.98	1.1	131.74	116.18	16.32
Net Cash Flow	60.38	-172.3	69.73	81.28	63.93
Free Cash Flow	-80.16	-75.54	-62.01	-38.59	47.61
Free Cash Flow Margin	-875.08%	-483.67%	-200.14%	-419.75%	346.19%
Free Cash Flow Per Share	-1.92	-2.09	-2.22	-13.96	17.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).